Generated by AI
Nemaura Medical Inc. is a medical technology company specializing in the development and commercialization of non-invasive, wearable diagnostic devices aimed at chronic disease management. The company is best known for SugarBEAT®, a wearable continuous glucose monitoring system designed to provide real-time glucose trend data for individuals with Type I and Type II diabetes, as well as those with pre-diabetic conditions. SugarBEAT® operates via a disposable skin patch connected to a rechargeable transmitter, delivering glucose readings to a mobile application at five-minute intervals for up to 24 hours at a time. Nemaura’s portfolio extends beyond diabetes care, encompassing digital health solutions for weight management, Type 2 diabetes prevention, and continuous lactate and temperature monitoring for medical and wellness applications. By offering non-invasive alternatives to traditional diagnostic methods, Nemaura Medical aims to empower patients and healthcare providers with affordable tools for better disease monitoring and personalized health management, with a particular focus on enhancing the quality of life for those managing chronic conditions.
Website57 West 57th Street
New York, NY, 10019
United States
Summary of Jan 3's posts. Generated by AI.
Summary of Jun 4's posts. Generated by AI.
No summary yet.
Summary of Jan 27's posts. Generated by AI.
Investors talking about NMRD also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.